CTVA — Corteva, Inc.
—
NYSE ·
Unknown ·
Unknown ·
CIK 1755672 ·
Last close
$75.79
Market Cap
$50.57B
52W High
$90.97
52W Low
$74.42
ADV30
4,276,667
Next earnings
2026-07-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 4,905,000,000 | 2,533,000,000 | 1,155,000,000 | 720,000,000 | 42,717,000,000 | 1,964,000,000 | 18,112,000,000 |
| Dec 2025 | 3,910,000,000 | 1,656,000,000 | 242,000,000 | -552,000,000 | 42,845,000,000 | 4,521,000,000 | 18,459,000,000 |
| Sep 2025 | 2,618,000,000 | 974,000,000 | -270,000,000 | -320,000,000 | 42,198,000,000 | 2,509,000,000 | 16,737,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,673,000,000
Investing CF
$-586,000,000
Financing CF
$-2,250,000,000
CapEx
$-578,000,000
Dividends Paid
$-480,000,000
Buybacks
$-1,051,000,000
EPS Diluted TTM
$1.51
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$436,000,000
Inventory
$5,202,000,000
Receivables
$9,088,000,000
ST Investments
$2,000,000
EBIT TTM
$1,942,000,000
Pretax Income TTM
$1,762,000,000
Interest Exp TTM
$180,000,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$17,812,000,768
EBITDA
$4,275,000,064
Free Cash Flow
$2,417,250,048
Enterprise Value
$53,320,785,920
Total Cash
$2,364,999,936
Total Debt
$4,874,999,808
Shares Out
667,196,000
Trailing EPS
$1.65
Book Value
$37.72
ROE
4.3%
ROA
4.5%
Div Yield
0.95%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 17,401,000,000 | 2,619,000,000 | 1,094,000,000 | 42,845,000,000 | 18,459,000,000 | — | 3,406,000,000 |
| Dec 2024 | 16,908,000,000 | 2,096,000,000 | 907,000,000 | 40,825,000,000 | 16,795,000,000 | — | 2,145,000,000 |
| Dec 2023 | 17,226,000,000 | 2,110,000,000 | 735,000,000 | 42,996,000,000 | 17,717,000,000 | — | 1,769,000,000 |
| Dec 2022 | 17,455,000,000 | 1,928,000,000 | 1,147,000,000 | 42,618,000,000 | 17,077,000,000 | — | 872,000,000 |
TTM Snapshot
Revenues TTM
$15,520,000,000
NetIncome TTM
$627,000,000
OpCashFlow TTM
$0
Assets (Latest)
$41,908,000,000
Forward EPS
$4.12
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $80.00 · spot: $75.79 · call volume: 156 · put volume: 634
Expected Move to 2026-10-16:
±$6.55
(8.64%) —
implied range
$69.24 –
$82.34
· ATM straddle on $75.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| WAB | WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP | $50.33B | $297.98 | — |
| GALDY | Galderma Group AG/ADR | $51.17B | $43.89 | — |
| NKE | NIKE, Inc. | $49.56B | $41.23 | — |
| ROK | ROCKWELL AUTOMATION, INC | $49.47B | $445.51 | — |
| GDERF | Galderma Group AG/ADR | $49.13B | $210.70 | — |
News headlines (Yahoo Finance, 1h cache)
Are Wall Street Analysts Bullish on Corteva Stock?
2026-08-10 13:34 · Yahoo
Corteva Announces Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
2026-08-06 20:15 · Yahoo
Corteva Inc (CTVA) (Q2 2026) Earnings Call Highlights: Strong First-Half Performance and Raised ...
2026-07-31 21:00 · Yahoo
Corteva Q2 Earnings Call Highlights
2026-07-31 18:04 · Yahoo
Are You Looking for a Top Momentum Pick? Why Corteva, Inc. (CTVA) is a Great Choice
2026-07-31 16:00 · Yahoo
DOLE vs. CTVA: Which Stock Is the Better Value Option?
2026-08-13 15:40 · Yahoo
Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers
2026-08-12 18:19 · Yahoo
Corteva Growth Improves, But Valuation Limits Upside
2026-08-12 18:15 · Yahoo
Can Expanding Avocado Consumption Benefit Mission Produce?
2026-08-10 16:39 · Yahoo
New Jersey's $2.5 billion settlements with DuPont, 3M, others approved
2026-08-07 21:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.